ArticleJournal of medicine and life2023

Molecular and serological biomarkers to predict trastuzumab responsiveness in HER-2 positive breast cancer.

Noor Abdullah et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.